INSIGHTS ON LIQUID DOSE MANUFACTURING
-
MPLC System: Efficient Purification for Mid-Sized Therapeutics
Discover how to enhance purification for mid-sized therapeutics with advanced pressure capabilities. Learn to balance automation and regulatory compliance for more reliable, precise batches.
-
Reading Between The Lines: How To Evaluate Decontamination Cycle Time Claims
Comparing isolator decontamination cycle times requires evaluating key variables like aeration endpoints and load patterns to build accurate capacity models and avoid costly delays.
-
Spray Dried Biologics For Nasal Dosage Forms
A fireside chat explores spray drying for nasal biologics, covering formulation science, particle design, delivery advantages, and testing strategies to move from concept to clinic.
-
Expanding Subcutaneous Design Brick By Brick
Biologics are growing more complex. But what if the syringe itself could unlock new possibilities? Discover the technology “bricks” quietly reshaping subcutaneous drug delivery.
-
Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality5/12/2026
Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.
-
Design Verification Done Right: Smarter Strategies For Prefillable Syringes9/29/2026
A practical framework for planning and justifying design verification programs for prefillable syringes, covering test selection, acceptance criteria, and sample-size rationale within a risk-based approach.
-
Planning For Scale Up: Building For Long Term Flexibility8/31/2026
Decisions made during clinical manufacturing have lasting consequences at commercial scale. This article examines how fill/finish equipment choices shape long-term flexibility, throughput, and operational continuity.
-
The Clear Solution: Navigating Contamination Control For Ophthalmic Injectables8/12/2026
As the intravitreal therapy market grows and applicable regulations evolve, continued compliance demands technological savvy and rigorous contamination control.
-
BioTitan Retention Device Overview5/29/2025
Learn about a retention device that provides robust fortification for single-use assemblies. Its 360-degree seal strengthens connections, reduces leak risks, and ensures process integrity for fluid transfer.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
BPCs are single-use, flexible container systems commonly used for critical liquid-handling applications in the biopharmaceutical industry.
-
Our Rigid Stainless Steel Containment Isolators have been designed for handling potent compounds that can offer guaranteed levels of operator protection as low as 10ng/m3 (task duration). These include designs for sampling, dispensing and sub-division, mixing, milling and vessel charging, as well as containing integrated process devices such as filter dryer units, tablet press enclosures, blenders, mills and pack off systems.
-
Moving cell and gene therapies toward commercial production requires tailored automation, careful material handling, and scalable processes. Combining scientific knowledge with production expertise can help manufacturers achieve consistent quality while protecting sensitive cell-based products.
-
ASEPTICARE offers a versatile, closed aseptic environment, ideal for aseptic and aseptic-toxic operations. It ensures contamination control and improves operational efficiency across various sterile processes.
-
The BD UltraSafe Plus™ passive needle guard for pre-filled ISO standard glass syringes is designed to support viscous drug delivery with ergonomics and drug visibility.